Drug Profile
Leuprolide intravaginal ring - Catalent
Alternative Names: Leuprolide IVR - Juniper pharmaceuticalLatest Information Update: 18 Nov 2021
Price :
$50
*
At a glance
- Originator Juniper Pharmaceuticals
- Developer Catalent
- Class Antineoplastics; Gonadotropins; Infertility therapies; Oligopeptides; Pituitary hormone releasing hormones
- Mechanism of Action Gonadotropin releasing hormone stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 28 Jun 2019 No recent reports of development identified for phase-I development in Unspecified(In volunteers) in USA (Vaginal, Ring)
- 05 May 2016 Phase-I clinical trials in Undefined indication (In volunteers) in USA (Vaginal) before May 2016